ImatinibMesylate相关论文
Is three years duration of adjuvant Imatinib Mesylate treatment sufficient for patients with high-ri
...
Influence of SLCO1B3 genetic polymorphisms on the incidence of adverse effects and trough plasma con
Background: Imatinib(Marketed as Glivec in USA and Gleevec in Europe)is a tyrosine kinase inhibitor(TKI),commonly used a......
目的探讨甲磺酸伊马替尼（IM）及其活性代谢产物N-去甲基伊马替尼（NDI）稳态血浆谷浓度（谷浓度）对胃肠间质瘤（GIST）患者中重度不良反应发生风......
目的总结胃肠道间质瘤非同期肝转移的诊断及治疗经验。方法回顾性分析13例胃肠道间质瘤非同期肝转移的临床资料。结果本组13例，均为......
目的分析胃肠间质瘤（GIST）的临床特点及治疗方法。方法对2000年7月至2015年9月在洛阳市第二中医院外科住院经手术病理证实的86例GIST......
Imatinib mesylate is a drug that has been approved for treatment of chronic myeloid leukemia (CML) in blast crisis, acce......
Development of multiple myeloma in a patient with gastrointestinal stromal tumor treated with imatin
Gastrointestinal stromal tumors (GISTs) are rare tumors,which represent approximately 1% of the neoplasms of the gastroi......
Objective: To study the effects of PDGF-Rb antagonists imatinib on endometrial injury repairing in the mouse model. Meth......
...
Pathologic complete response confirmed by surgical resection for liver metastases of gastrointestina
A 39-year-old male underwent distal gastrectomy for a high grade gastrointestinal stromal tumor (GIST). Computed tomogra......
Bilateral Masculine Mastoplasia Associated with Imatinib Mesylate: A Case Report and Literature Revi
1 CASE REPORT In June 2009,a 29-year-old Chinese male was diagnosed as having Philadelphia chromosome-positive chronic m......
Surgical treatments including radical resection and local excision remain the main treatment for primary rectal gastroin......
目的 探讨胃间质瘤(GST)的临床表现、病理特征及临床诊治措施.方法 对本院1996年6月-2006年6月10年问收治的经手术和病理组织学确......
1例59岁男性患者，6个月前确诊为慢性粒细胞白血病(CML)，口服甲磺酸伊马替尼(格列卫)400mg/d治疗。2个月前感冒后患者出现活动后气短，......
介绍一种抗癌新药:imatinib mesylate,对其作用机理、药动学、临床研究、安全性、不良反应及与其他药物的相互作用进行了阐述.......
